Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-18-003147
Filing Date
2018-03-19
Accepted
2018-03-19 16:36:46
Documents
47
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 2 TO QUARTERLY REPORT f10q1216a2_americanbrivision.htm 10-Q/A 311470
2 CERTIFICATION f10q1216a2ex31-1_american.htm EX-31.1 9344
3 CERTIFICATION f10q1216a2ex31-2_american.htm EX-31.2 9487
4 CERTIFICATION f10q1216a2ex32-1_american.htm EX-32.1 3832
5 CERTIFICATION f10q1216a2ex32-2_american.htm EX-32.2 3723
  Complete submission text file 0001213900-18-003147.txt   2018608

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20161231.xml EX-101.INS 288409
7 XBRL SCHEMA FILE mtoo-20161231.xsd EX-101.SCH 27066
8 XBRL CALCULATION FILE mtoo-20161231_cal.xml EX-101.CAL 20504
9 XBRL DEFINITION FILE mtoo-20161231_def.xml EX-101.DEF 70050
10 XBRL LABEL FILE mtoo-20161231_lab.xml EX-101.LAB 179010
11 XBRL PRESENTATION FILE mtoo-20161231_pre.xml EX-101.PRE 152211
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 18699230
SIC: 2834 Pharmaceutical Preparations